SNPs | T4 Me (Q1- Q3) | TSH Me (Q1- Q3) | anti-TPO Me (Q1- Q3) | |
---|---|---|---|---|
Exp1 | rs1048943 AA AG + GG | 11.6 (10.7–12.5) | 2.0 (1.3–3.0) | 0.4 (0.1–4.3) |
rs4646421 AA AG + GG | 11.7 (10.8–12.5)* | 2.0 (1.3–3.0) | 0.4 (0.1–3.5) | |
rs2070676 CC CG + GG | 11.7 (10.8–12.5) | 2.0 (1.3–3.0) | 0.4 (0.1–6.8) | |
rs3813867 CC CG + GG | 11.7 (10.8–12.5) | 1.9 (1.3–2.9) | 0.4 (0.1–3.5) | |
rs1695 AA AG + GG | 11.7 (10.8–12.5) | 2.0 (1.3–3.0) | 0.4 (0.1–5.1) | |
Exp2 | rs1048943 AA AG + GG | 12.2 (11.5–13.1) | 1.8 (1.3–2.8) | 0.3 (0.2–0.9) |
rs4646421 AA AG + GG | 12.3 (11.5–13.2) | 1.6 (1.1–2.8) | 0.3 (0.2–0.9) | |
rs2070676 CC CG + GG | 12.3 (11.5–13.2) | 1.7 (1.1–2.8) | 0.4 (0.2–0.9) | |
rs3813867 CC CG + GG | 12.2 (11.5–13.1) | 1.6 (1.1–2.8) | 0.3 (0.2–0.8) | |
rs1695 AA AG + GG | 12.3 (11.6–13.2) | 1.8 (1.3–2.9) | 0.3 (0.2–0.8) | |
Unexp | rs1048943 AA AG + GG | 12.0 (11.3–13.2) | 1.7 (1.2–2.9) | 0.3 (0.2–0.9) |
rs4646421 AA AG + GG | 12.0 (11.1–13.0) | 1.7 (1.2–2.9) | 0.3 (0.2–1.3) | |
rs2070676 CC CG + GG | 12.2 (11.3–13.3) | 2.0 (1.0–3.0) | 0.4 (0.2–0.9) | |
rs3813867 CC CG + GG | 12.0 (11.3–13.1) | 1.7 (1.2–2.9) | 0.3 (0.2–1.3) | |
rs1695 AA AG + GG | 12.2 (11.3–13.3) | 1.3 (1.0–2.0) | 0.3 (0.2–0.3) |